63 related articles for article (PubMed ID: 38549930)
21. Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features.
Sloan EA; Hilz S; Gupta R; Cadwell C; Ramani B; Hofmann J; Kline CN; Banerjee A; Reddy A; Oberheim Bush NA; Chang S; Braunstein S; Chang EF; Raffel C; Gupta N; Sun PP; Kim JYH; Moes G; Alva E; Li R; Bruggers CS; Alashari M; Wetmore C; Garg S; Dishop M; Van Ziffle J; Onodera C; Devine P; Grenert JP; Lee JC; Phillips JJ; Pekmezci M; Tihan T; Bollen AW; Berger MS; Costello JF; Perry A; Solomon DA
Acta Neuropathol; 2020 May; 139(5):953-957. PubMed ID: 32157385
[No Abstract] [Full Text] [Related]
22. Germline genetic landscape of pediatric central nervous system tumors.
Muskens IS; Zhang C; de Smith AJ; Biegel JA; Walsh KM; Wiemels JL
Neuro Oncol; 2019 Nov; 21(11):1376-1388. PubMed ID: 31247102
[TBL] [Abstract][Full Text] [Related]
23. Turcot syndrome. Rare observation and literature review.
Ozerov SS; Zakharov IV; Talypov SR; Konovalov DM; Kisliakov AN; Kachanov DIu; Zheludkova OG; Varfolomeeva SR; Rachkov VE
Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(3):49-53; discussion 53. PubMed ID: 23866578
[TBL] [Abstract][Full Text] [Related]
24. Turcot syndrome: a synchronous clinical presentation of glioblastoma multiforme and adenocarcinoma of the colon.
Dipro S; Al-Otaibi F; Alzahrani A; Ulhaq A; Al Shail E
Case Rep Oncol Med; 2012; 2012():720273. PubMed ID: 23119205
[TBL] [Abstract][Full Text] [Related]
25. Turcot syndrome type 2: medulloblastoma with multiple colorectal adenomas.
Skomorowski M; Taxier M; Wise W
Clin Gastroenterol Hepatol; 2012 Oct; 10(10):A24. PubMed ID: 22732270
[No Abstract] [Full Text] [Related]
26. Molecular subgroups of medulloblastoma: the current consensus.
Taylor MD; Northcott PA; Korshunov A; Remke M; Cho YJ; Clifford SC; Eberhart CG; Parsons DW; Rutkowski S; Gajjar A; Ellison DW; Lichter P; Gilbertson RJ; Pomeroy SL; Kool M; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):465-72. PubMed ID: 22134537
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Cancer Genome Atlas Research Network
Nature; 2008 Oct; 455(7216):1061-8. PubMed ID: 18772890
[TBL] [Abstract][Full Text] [Related]
28. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.
Pfister S; Janzarik WG; Remke M; Ernst A; Werft W; Becker N; Toedt G; Wittmann A; Kratz C; Olbrich H; Ahmadi R; Thieme B; Joos S; Radlwimmer B; Kulozik A; Pietsch T; Herold-Mende C; Gnekow A; Reifenberger G; Korshunov A; Scheurlen W; Omran H; Lichter P
J Clin Invest; 2008 May; 118(5):1739-49. PubMed ID: 18398503
[TBL] [Abstract][Full Text] [Related]
29. Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases.
TURCOT J; DESPRES JP; ST PIERRE F
Dis Colon Rectum; 1959; 2():465-8. PubMed ID: 13839882
[No Abstract] [Full Text] [Related]
30. Genetic predisposition and screening in pediatric cancer.
Pakakasama S; Tomlinson GE
Pediatr Clin North Am; 2002 Dec; 49(6):1393-413. PubMed ID: 12580371
[TBL] [Abstract][Full Text] [Related]
31. Role of Wnt pathway in medulloblastoma oncogenesis.
Yokota N; Nishizawa S; Ohta S; Date H; Sugimura H; Namba H; Maekawa M
Int J Cancer; 2002 Sep; 101(2):198-201. PubMed ID: 12209999
[TBL] [Abstract][Full Text] [Related]
32. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
Dahmen RP; Koch A; Denkhaus D; Tonn JC; Sörensen N; Berthold F; Behrens J; Birchmeier W; Wiestler OD; Pietsch T
Cancer Res; 2001 Oct; 61(19):7039-43. PubMed ID: 11585731
[TBL] [Abstract][Full Text] [Related]
33. The molecular basis of Turcot's syndrome.
Hamilton SR; Liu B; Parsons RE; Papadopoulos N; Jen J; Powell SM; Krush AJ; Berk T; Cohen Z; Tetu B
N Engl J Med; 1995 Mar; 332(13):839-47. PubMed ID: 7661930
[TBL] [Abstract][Full Text] [Related]
34. Case report: Turcot syndrome type 2 in a developing country within the Caribbean.
Daniel-Abdool M; Griffith B; Bartels U; Bodkyn C; Dindial K
Front Oncol; 2024; 14():1331271. PubMed ID: 38549930
[TBL] [Abstract][Full Text] [Related]
35. Systemic considerations with pigmented fundus lesions and retinal pigment epithelium hamartomas in Turcot syndrome.
Mokhashi N; Cai LZ; Shields CL; Benson WE; Ho AC
Curr Opin Ophthalmol; 2021 Nov; 32(6):567-573. PubMed ID: 34456292
[TBL] [Abstract][Full Text] [Related]
36. [Turcot syndrome].
Sunahara M; Nakagawara A
Nihon Rinsho; 2000 Jul; 58(7):1484-9. PubMed ID: 10921328
[TBL] [Abstract][Full Text] [Related]
37. The therapy of infantile malignant brain tumors: current status?
Kalifa C; Grill J
J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
[TBL] [Abstract][Full Text] [Related]
38. Pinealoblastoma in a patient with familial adenomatous polyposis: variant of Turcot syndrome type 2? Report of a case and review of the literature.
Gadish T; Tulchinsky H; Deutsch AA; Rabau M
Dis Colon Rectum; 2005 Dec; 48(12):2343-6. PubMed ID: 16400511
[TBL] [Abstract][Full Text] [Related]
39. [Turcot syndrome and Gardner's syndrome in a female patient with familial colon adenomatosis. A case report and literature review].
Kuz'minov AM; Vyshegorodtsev DV; Toboeva MK; Korolik VY; Gavryushin AV; Maynovskaya OA; Tsukanov AS
Zh Vopr Neirokhir Im N N Burdenko; 2019; 83(6):72-77. PubMed ID: 32031170
[TBL] [Abstract][Full Text] [Related]
40. Medulloblastoma: molecular genetics and animal models.
Raffel C
Neoplasia; 2004; 6(4):310-22. PubMed ID: 15256053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
